HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of unusually high doses of tranexamic acid for the treatment of epistaxis in hereditary hemorrhagic telangiectasia.

AuthorsC Sabbà, M Gallitelli, G Palasciano
JournalThe New England journal of medicine (N Engl J Med) Vol. 345 Issue 12 Pg. 926 (Sep 20 2001) ISSN: 0028-4793 [Print] United States
PMID11565536 (Publication Type: Case Reports, Comment, Letter)
Chemical References
  • Antifibrinolytic Agents
  • Tranexamic Acid
Topics
  • Aged
  • Antifibrinolytic Agents (administration & dosage)
  • Epistaxis (drug therapy, etiology)
  • Humans
  • Male
  • Telangiectasia, Hereditary Hemorrhagic (complications)
  • Tranexamic Acid (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: